Horizon Diagnostics has an innovative culture and is committed to delivering products that will improve molecular assays in oncology and in other fields. Although our focus to date has been on providing molecular reference standards to meet the needs of the oncology space, we are working towards also supporting areas including infectious diseases, neo-natal testing, and hereditary diseases, and are open to partnership discussions.
Horizon Diagnostics has a highly successful track record of working with a broad range of partners including large pharma and platform developers, as well as proficiency schemes from around the world.
We believe in establishing strong partnerships to deliver the best science, and believe there is real value in transitioning our products from research use only into the clinic. To support this effort Horizon has developed a strong Quality Management System and is currently certified to ISO 9001 and ISO 13485.
Please Contact Us to discuss your partnership opportunities.
Paragraph explaining benefits of Biocair×